These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37578068)

  • 1.
    Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
    Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.
    Bhandari P; Ahmad F; Mandava S; Das BR
    Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
    Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of ARID5B, IKZF1, PIP4K2A, and GATA3 Gene Polymorphisms to Childhood Acute Lymphoblastic Leukemia in a Chinese Population.
    Liu X; Xiao M; Xing Z; Jiang H; Zhu C; Zhang X; Li W; Wang Z; Wu F; Chen Y
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):123-129. PubMed ID: 36952466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
    Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
    Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
    Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.
    Wang Y; Chen J; Li J; Deng J; Rui Y; Lu Q; Wang M; Tong N; Zhang Z; Fang Y
    Gene; 2013 Jul; 524(2):203-7. PubMed ID: 23608171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan.
    Lin CY; Li MJ; Chang JG; Liu SC; Weng T; Wu KH; Yang SF; Huang FK; Lo WY; Peng CT
    Blood Cells Mol Dis; 2014; 52(2-3):140-5. PubMed ID: 24200646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
    Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
    Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
    Sattarzadeh Bardsiri M; Zehtab S; Karami N; Farsinejad A; Ehsan M; Fatemi A
    BMC Med Genomics; 2022 Aug; 15(1):171. PubMed ID: 35932035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.
    Peyrouze P; Guihard S; Grardel N; Berthon C; Pottier N; Pigneux A; Cahn JY; Béné MC; Lhéritier V; Delabesse E; Macintyre E; Thomas X; Dombret H; Ifrah N; Cheok M
    Br J Haematol; 2012 Dec; 159(5):599-602. PubMed ID: 23016962
    [No Abstract]   [Full Text] [Related]  

  • 12. ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia.
    Emerenciano M; Barbosa TC; Lopes BA; Blunck CB; Faro A; Andrade C; Meyer C; Marschalek R; Pombo-de-Oliveira MS;
    BMC Cancer; 2014 Feb; 14():127. PubMed ID: 24564228
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Mosaad YM; Khashaba M; Darwish A; Darwish M; Elwassefy M; Abdelmabood S; Fawzy IM; Youssef LF; Elbasiouny RA
    Pediatr Hematol Oncol; 2019 Sep; 36(6):365-375. PubMed ID: 31424309
    [No Abstract]   [Full Text] [Related]  

  • 14. Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study Group.
    Bartram T; Burkhardt B; Wössmann W; Seidemann K; Zimmermann M; Cario G; Lisfeld J; Ellinghaus E; Franke A; Houlston RS; Schrappe M; Reiter A; Stanulla M
    Leuk Lymphoma; 2015 Mar; 56(3):814-6. PubMed ID: 25005032
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.
    Pastorczak A; Górniak P; Sherborne A; Hosking F; Trelińska J; Lejman M; Szczepański T; Borowiec M; Fendler W; Kowalczyk J; Houlston RS; Młynarski W
    Leuk Res; 2011 Nov; 35(11):1534-6. PubMed ID: 21889209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.
    Burmeister T; Bartels G; Gröger D; Trautmann H; Schwartz S; Lenz K; Tietze-Bürger C; Viardot A; Wäsch R; Horst HA; Reinhardt R; Gökbuget N; Hoelzer D; Kneba M; Brüggemann M
    Haematologica; 2014 Feb; 99(2):e23-5. PubMed ID: 24497567
    [No Abstract]   [Full Text] [Related]  

  • 17. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
    Brown AL; de Smith AJ; Gant VU; Yang W; Scheurer ME; Walsh KM; Chernus JM; Kallsen NA; Peyton SA; Davies GE; Ehli EA; Winick N; Heerema NA; Carroll AJ; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Feingold E; Devidas M; Barcellos LF; Hansen HM; Morimoto L; Kang AY; Smirnov I; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson P; Spector LG; Pombo-de-Oliveira MS; DeWan AT; Mullighan CG; Hunger SP; Pui CH; Loh ML; Zwick ME; Metayer C; Ma X; Mueller BA; Sherman SL; Wiemels JL; Relling MV; Yang JJ; Lupo PJ; Rabin KR
    Blood; 2019 Oct; 134(15):1227-1237. PubMed ID: 31350265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population.
    Bahari G; Hashemi M; Naderi M; Taheri M
    Tumour Biol; 2016 Jul; 37(7):9579-86. PubMed ID: 26790447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
    Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
    J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.
    Rudant J; Orsi L; Bonaventure A; Goujon-Bellec S; Baruchel A; Petit A; Bertrand Y; Nelken B; Pasquet M; Michel G; Saumet L; Chastagner P; Ducassou S; Réguerre Y; Hémon D; Clavel J
    PLoS One; 2015; 10(3):e0121348. PubMed ID: 25806972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.